Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/28/2012US20120165364 Novel forms of tiotropium bromide and processes for preparation thereof
06/28/2012US20120165363 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders
06/28/2012US20120165362 Androgen receptor modulator compounds and methods
06/28/2012US20120165361 Drug coating providing high drug loading and methods for providing the same
06/28/2012US20120165360 Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
06/28/2012US20120165359 Opioid Agonist/Antagonist Combinations
06/28/2012US20120165358 Controlled release formulations of opioid and nonopioid analgesics
06/28/2012US20120165357 Compositions Containing Berberine or Analogs Thereof for Treating Rosacea or Red Face Related Skin Disorders
06/28/2012US20120165356 Spirocyclic heterocyclic derivatives and methods of their use
06/28/2012US20120165355 Methods and compositions for treating cancers
06/28/2012US20120165354 Treatment method
06/28/2012US20120165353 Novel phenylpyridine derivative and medicinal agent comprising same
06/28/2012US20120165352 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
06/28/2012US20120165351 Quinazoline derivatives
06/28/2012US20120165350 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
06/28/2012US20120165349 Phenyl-Substituted Pyrazolopyrimidines
06/28/2012US20120165348 Novel compounds
06/28/2012US20120165347 Compounds and their use as BACE Inhibitors
06/28/2012US20120165346 Compounds and their use as BACE inhibitors
06/28/2012US20120165344 Compounds for the Treatment of Hepatitis C
06/28/2012US20120165343 Glucagon Receptor Modulators
06/28/2012US20120165342 Methods of Reducing Risk of Infection from Pathogens
06/28/2012US20120165341 Therapeutic agent for senile dementia
06/28/2012US20120165340 Pten phosphorylation-driven resistance to cancer treatment and altered patient prognosis
06/28/2012US20120165339 Cyclopropane derivatives
06/28/2012US20120165338 New biaryl amide derivatives
06/28/2012US20120165337 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/28/2012US20120165336 Color Change Time Indicator for Packaging System
06/28/2012US20120165335 Cdk inhibitors
06/28/2012US20120165334 Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors
06/28/2012US20120165333 C-met protein kinase inhibitors
06/28/2012US20120165332 Sulfonamides and sulfamides as zap-70 inhibitors
06/28/2012US20120165331 Di/tri-aza-spiro-C9-C11alkanes
06/28/2012US20120165330 Quinazolinone and related analogs as sirtuin modulators
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165328 Inhibitors of b lymphocyte kinase
06/28/2012US20120165327 Spiropiperidines for use as tryptase inhibitors
06/28/2012US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
06/28/2012US20120165325 Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide
06/28/2012US20120165324 Therapeutic compositions and related methods of use
06/28/2012US20120165323 Method for improving the dissolution profile of a biologically active material
06/28/2012US20120165322 Rho kinase inhibitors
06/28/2012US20120165321 Quinoline derivatives as pi3 kinase inhibitors
06/28/2012US20120165320 Novel azabicyclohexanes
06/28/2012US20120165319 Inhibitors of interleukin-1 beta converting enzyme
06/28/2012US20120165318 Heterocyclic compounds for the inhibition of pask
06/28/2012US20120165317 8-substituted benzoazepines as toll-like receptor modulators
06/28/2012US20120165316 Substituted hydroxamic acids and uses thereof
06/28/2012US20120165315 Meptazinol carbamate prodrug salts
06/28/2012US20120165314 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/28/2012US20120165313 Pyrimidine compounds, compositions and methods of use
06/28/2012US20120165312 Fused heterocyclic compound and use thereof
06/28/2012US20120165311 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
06/28/2012US20120165310 Ether derivatives of bicyclic heteroaryls
06/28/2012US20120165309 Hetero ring derivative
06/28/2012US20120165308 Use of parthenolide derivatives as antileukemic and cytotoxic agents
06/28/2012US20120165307 Azaindoles useful as inhibitors of janus kinases
06/28/2012US20120165306 Pyrazinylpyridines useful for the treatment of proliferative diseases
06/28/2012US20120165305 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
06/28/2012US20120165304 6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/28/2012US20120165303 Triazolyl phenyl benzenesulfonamides
06/28/2012US20120165302 Antifungal formulations
06/28/2012US20120165301 Benzodiazepine compositions for treating epidermal hyperplasia and related disorders
06/28/2012US20120165300 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
06/28/2012US20120165299 Combination medicament
06/28/2012US20120165298 Sulfonamide compounds
06/28/2012US20120165296 Bisphosphonate-prodrugs
06/28/2012US20120165295 Compounds, Compositions and Methods for Treating Ocular Conditions
06/28/2012US20120165294 4,5-dihydro-oxazol-2yl derivatives
06/28/2012US20120165293 Synthesis of prostanoids
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165291 Acidic composition for external use and agent for accelerating infiltration of cosmetic preparation, hair-growing agent, and preparation for external use each containing the composition into skin or the like
06/28/2012US20120165289 Treatment
06/28/2012US20120165288 Azapeptide derivatives
06/28/2012US20120165287 Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect
06/28/2012US20120165286 Cyclic nucleotide analogs
06/28/2012US20120165285 Combined preparation for use as a medicament
06/28/2012US20120165284 Pharmaceutical composition comprising a3 adenosine receptor agonist (ib-meca/cf-101) for treatment of psoriasis
06/28/2012US20120165283 Novel aminoglycoside antibiotics
06/28/2012US20120165282 Antibacterial aminoglycoside analogs
06/28/2012US20120165281 Stilbenoid derivatives and their uses
06/28/2012US20120165280 Method for improving blood flow using stilbenoid derivatives
06/28/2012US20120165279 Pharmaceutical composition and method for preventing or treating hepatitis c
06/28/2012US20120165278 Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same
06/28/2012US20120165277 Novel galactoside inhibitors of galectins
06/28/2012US20120165276 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
06/28/2012US20120165270 Inhibition of hair follicle growth by the wnt inhibitor dkk1
06/28/2012US20120165254 Sulphated hyaluronic acid for treating degenerative osteoarthritis
06/28/2012US20120165252 Method of Regulating Glucose Metabolism, and Reagents Related Thereto
06/28/2012US20120165251 Diabetes therapy
06/28/2012US20120165243 Use of dietary fibres against muscle wasting
06/28/2012US20120164637 Susceptibility to bone damage
06/28/2012US20120164265 Dietary Method for Modulating Glucose Metabolism
06/28/2012US20120164245 Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
06/28/2012US20120164243 Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders
06/28/2012US20120164242 Novel methods for modulating melanin production
06/28/2012US20120164233 Pulsatile release pharmaceutical formulation of dexlansoprazole
06/28/2012US20120164231 Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates
06/28/2012US20120164230 Soluble Nanoparticles as Delivery Systems for Prodrugs
06/28/2012US20120164228 Novel pharmaceutical formulations to prevent the misuse of medicinal drugs
1 ... 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 ... 7860